Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abraham, 1940, An enzyme from bacteria able to destroy penicillin, Nature, 146, 837, 10.1038/146837a0
Gaynes, 2005, Overview of nosocomial infections caused by gram-negative bacilli, Clin Infect Dis, 41, 848, 10.1086/432803
Wisplinghoff, 2004, Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study, Clin Infect Dis, 39, 309, 10.1086/421946
Joly-Guillo, 1988, Distribution of β-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus, J Antimicrob Chemother, 22, 597, 10.1093/jac/22.5.597
Blechschmidt, 1992, Purification and characterization of an extracellular β-lactamase produced by Acinetobacter calcoaceticus, J Gen Microbiol, 138, 1197, 10.1099/00221287-138-6-1197
Vila, 1993, In vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii, Antimicrob Agents Chemother, 37, 138, 10.1128/AAC.37.1.138
Corvec, 2003, AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains, J Antimicrob Chemother, 52, 629, 10.1093/jac/dkg407
Mammeri, 2003, Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to β-lactams, Antimicrob Agents Chemother, 47, 1536, 10.1128/AAC.47.5.1536-1542.2003
Lopez-Hernandez, 2001, Biochemical characterization of chromosomal cephalosporinases from isolates belonging to the Acinetobacter baumannii complex, Clin Microbiol Infect, 7, 218, 10.1046/j.1469-0691.2001.00222.x
Beceiro, 2004, Molecular characterization of the gene encoding a new AmpC β-lactamase in a clinical strain of Acinetobacter genomic species 3, Antimicrob Agents Chemother, 48, 1374, 10.1128/AAC.48.4.1374-1378.2004
Perilli, 1996, Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates, Antimicrob Agents Chemother, 40, 715, 10.1128/AAC.40.3.715
Bou, 2000, Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii, Antimicrob Agents Chemother, 44, 428, 10.1128/AAC.44.2.428-432.2000
Hujer, 2005, Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase: defining a unique family of class C enzymes, Antimicrob Agents Chemother, 49, 2941, 10.1128/AAC.49.7.2941-2948.2005
Segal, 2004, Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate, Antimicrob Agents Chemother, 48, 612, 10.1128/AAC.48.2.612-614.2004
Segal, 2003, Characterization of class 1 integron resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii, Plasmid, 49, 169, 10.1016/S0147-619X(03)00011-8
Bou, 2000, Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases, J Clin Microbiol, 38, 3299, 10.1128/JCM.38.9.3299-3305.2000
Huang, 2004, Study on the molecular epidemiology of SHV type β-lactamase-encoding genes of multiple-drug-resistant Acinetobacter baumannii, Zhonghua Liu Xing Bing Xue Za Zhi, 25, 425
Bergogne-Berezin, 1996, Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features, Clin Microbiol Rev, 9, 148, 10.1128/CMR.9.2.148
Nagano, 2004, Nosocomial transmission of CTX-M-2 β-lactamase-producing Acinetobacter baumannii in a neurosurgery ward, J Clin Microbiol, 42, 3978, 10.1128/JCM.42.9.3978-3984.2004
Vahaboglu, 1997, Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study, Antimicrob Agents Chemother, 41, 2265, 10.1128/AAC.41.10.2265
Yong, 2003, High prevalence of PER-1 extended-spectrum β-lactamase-producing Acinetobacter spp. in Korea, Antimicrob Agents Chemother, 47, 1749, 10.1128/AAC.47.5.1749-1751.2003
Poirel, 1999, Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France, J Antimicrob Chemother, 43, 157, 10.1093/jac/43.1.157
Poirel, 2003, Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital, J Clin Microbiol, 41, 3542, 10.1128/JCM.41.8.3542-3547.2003
Carbonne, 2005, Investigation of a nosocomial outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting, J Hosp Infect, 60, 14, 10.1016/j.jhin.2004.07.027
Zarrilli, 2004, Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance, J Clin Microbiol, 42, 946, 10.1128/JCM.42.3.946-953.2004
Brown, 2005, The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents, Clin Microbiol Infect, 11, 326, 10.1111/j.1469-0691.2005.01096.x
Navon-Venezia, 2005, Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting, Curr Opin Infect Dis, 18, 306, 10.1097/01.qco.0000171920.44809.f0
del Mar Tomas, 2005, Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonization and infection, Clin Microbiol Infect, 11, 540, 10.1111/j.1469-0691.2005.01184.x
Donald, 2000, Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92, Antimicrob Agents Chemother, 44, 196, 10.1128/AAC.44.1.196-199.2000
Heritier, 2005, Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii, Antimicrob Agents Chemother, 49, 3198, 10.1128/AAC.49.8.3198-3202.2005
Navia, 2002, Characterization of an integron carrying a new class D β-lactamase (OXA-37) in Acinetobacter baumannii, Microb Drug Resist, 8, 261, 10.1089/10766290260469516
Vila, 1997, Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived β-lactamase in Acinetobacter baumannii, Antimicrob Agents Chemother, 41, 2757, 10.1128/AAC.41.12.2757
Poirel, 2002, Integron-located oxa-32 gene cassette encoding an extended-spectrum variant of OXA-2 β-lactamase from Pseudomonas aeruginosa, Antimicrob Agents Chemother, 46, 566, 10.1128/AAC.46.2.566-569.2002
Poirel, 2001, OXA-28, an extended-spectrum variant of OXA-10 β-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene, Antimicrob Agents Chemother, 45, 447, 10.1128/AAC.45.2.447-453.2001
Yum, 2002, Molecular characterization of metallo-β-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes, J Antimicrob Chemother, 49, 837, 10.1093/jac/dkf043
Lee, 2004, Metallo-β-lactamase-producing gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp, Diagn Microbiol Infect Dis, 50, 51, 10.1016/j.diagmicrobio.2004.05.002
Walsh, 2005, Metallo-β-lactamases: the quiet before the storm?, Clin Microbiol Rev, 18, 306, 10.1128/CMR.18.2.306-325.2005
Da Silva, 2002, Molecular characterization of bla(IMP-5), a new integron-borne metallo-β-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal, FEMS Microbiol Lett, 215, 33
Quale, 2003, Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City, Clin Infect Dis, 37, 214, 10.1086/375821
Clark, 1996, Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 kDa outer membrane protein, J Antimicrob Chemother, 38, 245, 10.1093/jac/38.2.245
Limansky, 2002, Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance, J Clin Microbiol, 40, 4776, 10.1128/JCM.40.12.4776-4778.2002
Seward, 1998, Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp, J Med Microbiol, 47, 455, 10.1099/00222615-47-5-455
Nemec, 2004, Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones, J Med Microbiol, 53, 1233, 10.1099/jmm.0.45716-0
Vila, 1995, Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii, Antimicrob Agents Chemother, 39, 1201, 10.1128/AAC.39.5.1201
Vila, 1997, Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii, J Antimicrob Chemother, 39, 757, 10.1093/jac/39.6.757
Robicsek, 2005, Broader distribution of plasmid-mediated quinolone resistance in the United States, Antimicrob Agents Chemother, 49, 3001, 10.1128/AAC.49.7.3001-3003.2005
Nordmann, 2005, Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae, J Antimicrob Chemother, 56, 463, 10.1093/jac/dki245
Magnet, 2001, Resistance-modulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454, Antimicrob Agents Chemother, 45, 3375, 10.1128/AAC.45.12.3375-3380.2001
Marchand, 2004, Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system, Antimicrob Agents Chemother, 48, 3298, 10.1128/AAC.48.9.3298-3304.2004
Lister, 1999, Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin, Antimicrob Agents Chemother, 43, 882, 10.1128/AAC.43.4.882
Tausk, 1986, Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa, Antimicrob Agents Chemother, 30, 584, 10.1128/AAC.30.4.584
Livermore, 1987, Clinical significance of β-lactamase induction and stable derepression in gram-negative rods, Eur J Clin Microbiol, 6, 439, 10.1007/BF02013107
Boissinot, 1990, Nucleotide sequence of the PSE-4 carbenicillinase gene and correlations with the Staphylococcus aureus PC1 β-lactamase crystal structure, J Biol Chem, 265, 1225, 10.1016/S0021-9258(19)40181-6
Huovinen, 1991, Sequence of the PSE-1 β-lactamase gene, Antimicrob Agents Chemother, 35, 2428, 10.1128/AAC.35.11.2428
Lachapelle, 1991, Characterization of the blaCARB-3 gene encoding the carbenicillinase-3 β-lactamase of Pseudomonas aeruginosa, Gene, 102, 7, 10.1016/0378-1119(91)90530-O
Sanschagrin, 1998, Structure of CARB-4 and AER-1 carbenicillin-hydrolyzing β-lactamases, Antimicrob Agents Chemother, 42, 1966, 10.1128/AAC.42.8.1966
Danel, 1995, OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa, Antimicrob Agents Chemother, 39, 1881, 10.1128/AAC.39.8.1881
Danel, 1997, OXA-15, an extended-spectrum variant of OXA-2 β-lactamase, isolated from a Pseudomonas aeruginosa strain, Antimicrob Agents Chemother, 41, 785, 10.1128/AAC.41.4.785
Danel, 1999, OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa, Antimicrob Agents Chemother, 43, 1362, 10.1128/AAC.43.6.1362
Thabaut, 1985, β-lactamases of Pseudomonas aeruginosa and susceptibility against β-lactam antibiotics, Chemioterapia, 4, 36
Philippon, 1986, New plasmid-mediated oxacillin-hydrolyzing β-lactamase in Pseudomonas aeruginosa, J Antimicrob Chemother, 17, 415, 10.1093/jac/17.4.415
Medeiros, 1985, Five novel plasmid-determined β-lactamases, Antimicrob Agents Chemother, 27, 715, 10.1128/AAC.27.5.715
Livermore, 1995, β-lactamases in laboratory and clinical resistance, Clin Microbiol Rev, 8, 557, 10.1128/CMR.8.4.557
Hall, 1993, OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa, Antimicrob Agents Chemother, 37, 1637, 10.1128/AAC.37.8.1637
Danel, 1998, OXA-16, a further extended-spectrum variant of OXA-10 β-lactamase, from two Pseudomonas aeruginosa isolates, Antimicrob Agents Chemother, 42, 3117, 10.1128/AAC.42.12.3117
Mugnier, 1998, Novel OXA-10-derived extended-spectrum β-lactamases selected in vivo or in vitro, Antimicrob Agents Chemother, 42, 3113, 10.1128/AAC.42.12.3113
Mugnier, 1998, Carbapenems as inhibitors of OXA-13, a novel, integron-encoded β-lactamase in Pseudomonas aeruginosa, Microbiology, 144, 1021, 10.1099/00221287-144-4-1021
Philippon, 1997, OXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa, Antimicrob Agents Chemother, 41, 2188, 10.1128/AAC.41.10.2188
Aubert, 2001, Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa, Antimicrob Agents Chemother, 45, 1615, 10.1128/AAC.45.6.1615-1620.2001
Aubert, 2001, OXA-35 is an OXA-10-related β-lactamase from Pseudomonas aeruginosa, J Antimicrob Chemother, 48, 717, 10.1093/jac/48.5.717
Mugnier, 1996, A TEM-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa, Antimicrob Agents Chemother, 40, 2488, 10.1128/AAC.40.11.2488
Poirel, 1999, Extended-spectrum β-lactamase TEM-4 in Pseudomonas aeruginosa, Clin Microbiol Infect, 5, 651, 10.1111/j.1469-0691.1999.tb00425.x
Dubois, 2002, Clinical strain of Pseudomonas aeruginosa carrying a blaTEM-21 gene located on a chromosomal interrupted TnA type transposon, Antimicrob Agents Chemother, 46, 3624, 10.1128/AAC.46.11.3624-3626.2002
Marchandin, 2000, Production of a TEM-24 plasmid-mediated extended-spectrum β-lactamase by a clinical isolate of Pseudomonas aeruginosa, Antimicrob Agents Chemother, 44, 213, 10.1128/AAC.44.1.213-216.2000
Naas, 1999, An SHV-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa, Antimicrob Agents Chemother, 43, 1281, 10.1128/AAC.43.5.1281
Chanawong, 2001, SHV-12, SHV-5, SHV-2a, and VEB-1 extended-spectrum β-lactamases in gram-negative bacteria isolated in a university hospital in Thailand, J Antimicrob Chemother, 48, 839, 10.1093/jac/48.6.839
Paterson, 2003, Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases, Antimicrob Agents Chemother, 47, 3554, 10.1128/AAC.47.11.3554-3560.2003
Nordmann, 1993, Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa, Antimicrob Agents Chemother, 37, 962, 10.1128/AAC.37.5.962
Nordmann, 1994, Sequence analysis of PER-1 extended-spectrum β-lactamase from Pseudomonas aeruginosa and comparison with class A β-lactamases, Antimicrob Agents Chemother, 38, 104, 10.1128/AAC.38.1.104
Claeys, 2000, PER-1 β-lactamase-producing Pseudomonas aeruginosa in an intensive care unit, J Antimicrob Chemother, 45, 924, 10.1093/jac/45.6.924
De Champs, 2002, Prospective survey of β-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolated in a French hospital in 2000, Antimicrob Agents Chemother, 46, 3031, 10.1128/AAC.46.9.3031-3034.2002
Luzzaro, 2001, Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase, J Clin Microbiol, 39, 1865, 10.1128/JCM.39.5.1865-1870.2001
Docquier, 2001, Multidrug-resistant Pseudomonas aeruginosa producing PER-1 extended-spectrum serine-β-lactamase and VIM-2 metallo-β-lactamase, Emerg Infect Dis, 7, 910, 10.3201/eid0705.010528
Endimiani, 2006, Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase, BMC Infect Dis, 6, 52, 10.1186/1471-2334-6-52
Naas, 1999, Molecular characterisation of In51, a class 1 integron containing a novel aminoglycoside adenylyltransferase gene cassette, aadA6, in Pseudomonas aeruginosa, Biochim Biophys Acta, 1489, 445, 10.1016/S0167-4781(99)00202-X
Girlich, 2002, Nosocomial spread of the integron-located VEB-1-like cassette encoding an extended-spectrum β-lactamase in Pseudomonas aeruginosa in Thailand, Clin Infect Dis, 34, 603, 10.1086/338786
Poirel, 2001, VEB-1-like extended-spectrum β-lactamases in Pseudomonas aeruginosa, Kuwait, Emerg Infect Dis, 7, 468, 10.3201/eid0703.017322
Dubois, 2002, Molecular characterization of a novel class 1 integron containing blaGES-1 and a fused product of aac3-Ib/aac6′-Ib′ gene cassettes in Pseudomonas aeruginosa, Antimicrob Agents Chemother, 46, 638, 10.1128/AAC.46.3.638-645.2002
Poirel, 2001, GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem, Antimicrob Agents Chemother, 45, 2598, 10.1128/AAC.45.9.2598-2603.2001
Poirel, 2002, A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum β-lactamase GES-2 in South Africa, J Antimicrob Chemother, 49, 561, 10.1093/jac/49.3.561
Mavroidi, 2001, An integron-associated β-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum β-lactamase IBC-1, J Antimicrob Chemother, 48, 627, 10.1093/jac/48.5.627
Nordmann, 2002, Emerging carbapenemases in gram-negative aerobes, Clin Microbiol Infect, 8, 321, 10.1046/j.1469-0691.2002.00401.x
Toleman, 2002, Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme, J Antimicrob Chemother, 50, 673, 10.1093/jac/dkf210
Murphy, 2003, Biochemical characterization of the acquired metallo-β-lactamase SPM-1 from Pseudomonas aeruginosa, Antimicrob Agents Chemother, 47, 582, 10.1128/AAC.47.2.582-587.2003
Osano, 1994, Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance, Antimicrob Agents Chemother, 38, 71, 10.1128/AAC.38.1.71
Senda, 1996, Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems, Antimicrob Agents Chemother, 40, 349, 10.1128/AAC.40.2.349
Hirakata, 2003, Clinical and bacteriological characteristics of IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa, Clin Infect Dis, 37, 26, 10.1086/375594
Gibb, 2002, Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaIMP allele, blaIMP-7, Antimicrob Agents Chemother, 46, 255, 10.1128/AAC.46.1.255-258.2002
Ho, 2002, Carbapenem-resistant Pseudomonas aeruginosa in Malaysia producing IMP-7 β-lactamase, Antimicrob Agents Chemother, 46, 3286, 10.1128/AAC.46.10.3286-3287.2002
Toleman, 2003, Genetic characterization of a novel metallo-β-lactamase gene, blaIMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme, J Antimicrob Chemother, 52, 583, 10.1093/jac/dkg410
Cornaglia, 2000, Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase, Clin Infect Dis, 31, 1119, 10.1086/317448
Tsakris, 2000, Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece, J Clin Microbiol, 38, 1290, 10.1128/JCM.38.3.1290-1292.2000
Poirel, 2000, Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France, Antimicrob Agents Chemother, 44, 891, 10.1128/AAC.44.4.891-897.2000
Poirel, 2001, Characterization of class 1 integrons from Pseudomonas aeruginosa that contain the blaVIM-2 carbapenem-hydrolyzing β-lactamase gene and of two novel aminoglycoside resistance gene cassettes, Antimicrob Agents Chemother, 45, 546, 10.1128/AAC.45.2.546-552.2001
Cardoso, 2002, Metallo-β-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal, Microb Drug Resist, 8, 93, 10.1089/107662902760190635
Giakkoupi, 2003, Spread of integron-associated VIM-type metallo-β-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals, J Clin Microbiol, 41, 822, 10.1128/JCM.41.2.822-825.2003
Mavroidi, 2000, Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece, J Antimicrob Chemother, 46, 1041, 10.1093/jac/46.6.1041
Sardelic, 2003, Carbapenem-resistant Pseudomonas aeruginosa carrying VIM-2 metallo-β-lactamase determinants, Croatia, Emerg Infect Dis, 9, 1022, 10.3201/eid0908.020373
Oh, 2003, Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-β-lactamase, J Microbiol Methods, 54, 411, 10.1016/S0167-7012(03)00090-3
Lee, 2002, bla VIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital, Antimicrob Agents Chemother, 46, 1053, 10.1128/AAC.46.4.1053-1058.2002
Lee, 2003, VIM- and IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals, Emerg Infect Dis, 9, 868, 10.3201/eid0907.030012
Yan, 2001, Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme, Antimicrob Agents Chemother, 45, 2224, 10.1128/AAC.45.8.2224-2228.2001
Shibata, 2003, PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron, J Clin Microbiol, 41, 5407, 10.1128/JCM.41.12.5407-5413.2003
Lolans, 2005, First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States, Antimicrob Agents Chemother, 49, 3538, 10.1128/AAC.49.8.3538-3540.2005
Livermore, 1992, Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa, Antimicrob Agents Chemother, 36, 2046, 10.1128/AAC.36.9.2046
Horii, 2003, Characterization of Pseudomonas aeruginosa isolates from patients with urinary tract infections during antibiotic therapy, Microb Drug Resist, 9, 223, 10.1089/107662903765826831
Zanetti, 2003, Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study, Antimicrob Agents Chemother, 47, 3442, 10.1128/AAC.47.11.3442-3447.2003
Carmeli, 1999, Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents, Antimicrob Agents Chemother, 43, 1379, 10.1128/AAC.43.6.1379
Jaccard, 1998, Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis, Antimicrob Agents Chemother, 42, 2966, 10.1128/AAC.42.11.2966
Cometta, 1994, Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients, Antimicrob Agents Chemother, 38, 1309, 10.1128/AAC.38.6.1309
Miller, 1997, The most frequent aminoglycoside resistance mechanisms—changes with time and geographic area: a reflection of aminoglycoside usage patterns?. Aminoglycoside Resistance Study Groups, Clin Infect Dis, 24, 46, 10.1093/clinids/24.Supplement_1.S46
Pitt, 1990, Resistance mechanisms of multiresistant serotype 012 Pseudomonas aeruginosa isolated in Europe, J Antimicrob Chemother, 26, 319, 10.1093/jac/26.3.319
Vanhoof, 1993, Serotypes and extended spectrum β-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study, J Hosp Infect, 24, 129, 10.1016/0195-6701(93)90075-B
Higgins, 2003, Mutations in GyrA, ParC, MexR, and NfxB in clinical isolates of Pseudomonas aeruginosa, Int J Antimicrob Agents, 21, 409, 10.1016/S0924-8579(03)00009-8
Livermore, 2002, Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?, Clin Infect Dis, 34, 634, 10.1086/338782
Ochs, 1999, Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids, Antimicrob Agents Chemother, 43, 1085, 10.1128/AAC.43.5.1085
Denton, 2002, Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center, Pediatr Pulmonol, 34, 257, 10.1002/ppul.10166
Deplano, 2005, Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa, J Clin Microbiol, 43, 1198, 10.1128/JCM.43.3.1198-1204.2005